Investment
Features
FeesSafety
Academy
More
Pluang+

A $5.15M sell order in Ether contract shows slight market sell-side edge on Oct 9

Market News
09 Oct 2026
Tokenpost
View Source
Neutral
A $5.15M sell order in Ether contract shows slight market sell-side edge on Oct 9

On October 9, a large $5.15 million sell order for 2,064.49 Ether (ETH) was placed at $2,493.20, slightly above the market midpoint of $2,492.75. The nearby buy and sell orders were closely balanced, with buy orders totaling about $12.75 million and sell orders about $12.84 million, giving the sell side a small advantage of roughly $90,900 or 0.36% of total order-book depth. This indicates a subtle sell pressure in the Ether market at that time, reflecting cautious trading sentiment. Investors should watch for further order book changes to gauge market direction.

Hyperliquid Ether contract data provides context for cryptocurrency markets. For readers following crypto, here is Pluang's market snapshot as of Oct 09, 2026 17:21 WIB: Out of 50 major cryptocurrencies, 12 rose and 37 fell. Notable movers include ATOM at Rp34.899 with +8.47% change and 77% buy activity, EOS at Rp12.649 with +8.13% change, and BCH at Rp4.970.403 with -6.52% change and nearly balanced buy/sell orders.

More News

Sigenergy debuts AI-powered energy solutions and new partnerships at Malaysia's IGEM 2026.

Sigenergy debuts AI-powered energy solutions and new partnerships at Malaysia's IGEM 2026.

At Malaysia's IGEM 2026, Sigenergy showcased its latest AI-driven energy technologies, including smart storage and inverter systems, highlighting its role in advancing sustainable energy. The company also signed MOUs with local partners Milieu and YT...

Market News
Bullish
3 hours ago
Entrada Therapeutics rated Buy with $8.50 target, expects higher drug dosing results in 2027.

Entrada Therapeutics rated Buy with $8.50 target, expects higher drug dosing results in 2027.

Entrada Therapeutics is rated Buy with a fair value of $8.50, implying about 52% upside from the current $5.61 price. The company’s Duchenne muscular dystrophy drug ENTR-601-44 showed a disappointing initial increase in dystrophin, but this is attrib...

Analyst Insights
Neutral
4 hours ago
Ten-year Treasury yields hit 5.36% amid systemic debt concerns and strong stock market gains.

Ten-year Treasury yields hit 5.36% amid systemic debt concerns and strong stock market gains.

Ten-year U.S. Treasury yields reached 5.36% intraday, reflecting growing systemic sovereign debt issues. Despite these concerns, the stock market showed strength with the S&P 500 rising 1.2% and the Dow gaining 0.9%, supported by a 43-week expansion ...

Market News
Neutral
4 hours ago
Pump.fun's token buyback drops as daily revenue falls 16%, impacting price support until April 2027.

Pump.fun's token buyback drops as daily revenue falls 16%, impacting price support until April 2027.

Pump.fun's daily revenue, which funds half of its token buyback and burn program, fell 16% from $1.89 million on October 5 to $1.59 million on October 9, causing the token price to drop 16.8% from its weekly high. The buyback program, running until A...

Protocol Fundamentals
Bearish
4 hours ago
Alphamin Resources offers a promising buy with stable tin mines and growth potential in DRC.

Alphamin Resources offers a promising buy with stable tin mines and growth potential in DRC.

Alphamin Resources Corp. operates two profitable tin mines in the Democratic Republic of Congo and is focusing on exploration around its Bisie resource, offering speculative growth potential. The company's current operations are stable and profitable...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App